FIELD: medicine.
SUBSTANCE: invention refers to medicine and chemical-pharmaceutical industry, namely to suppositories for treating moderate and high-intensity pain syndrome. Pharmaceutical composition of the rectal suppository contains 0.1–10 g/100 g of nefopam or its pharmaceutically acceptable salt, from 90 to 100 % of particles of which have size from 0.5 to 90 mcm, and up to 100 g/100 g of a lipophilic base with addition of parabens, sodium benzoate, emulsifier and stabilizer.
EFFECT: invention provides prolonging the analgesic effect and improving retention of the active substance.
6 cl, 4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723958C1 |
| SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723954C1 |
| SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723952C1 |
| PHARMACEUTICAL COMPOSITIONS AS RECTAL SUPPOSITORIES CONTAINING NEFOPAM HYDROCHLORIDE (VERSIONS), THEIR APPLICATION FOR TREATMENT OF ACUTE AND CHRONIC PAIN SYNDROME AND METHODS FOR PRODUCTION | 2015 |
|
RU2646495C2 |
| NEPHOPAM SUPPOSITORIES FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN SYNDROME ON A HYDROPHILIC EMULSION BASED AND METHOD FOR THEIR PREPARATION | 2017 |
|
RU2661617C1 |
| NEPHOPAM SUPPOSITORIES FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN SYNDROME ON A LIPOPHILIC BASIS AND THE METHOD FOR THEIR PREPARATION | 2017 |
|
RU2661618C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING NALBUPHINE HYDROCHLORIDE, USING IT FOR TREATING MODERATE TO SEVERE PAIN SYNDROME | 2012 |
|
RU2513514C1 |
| PEPTIDE AGENT POSSESSING ANALGESIC ANTI-INFLAMMATORY ACTION, AND BASED DOSAGE FORMS | 2012 |
|
RU2528094C2 |
| AGENT OF PEPTIDE STRUCTURE POSSESSING ANTI-INFLAMMATORY, ANTIBACTERIAL, WOUND-HEALING, REGENERATIVE, ANALGESIC, BURNTREATING ACTION AND BASED DOSAGE FORMS | 2012 |
|
RU2517213C2 |
| METHOD OF TREATING CHRONIC PAIN SYNDROME | 2014 |
|
RU2545915C1 |
